2016 American Transplant Congress
Optimizing CPRAs for Sensitized Kidney Waitlist Candidates: The Devil Is in the KAS Details.
The new kidney allocation system (KAS) has increased transplant rates for highly sensitized candidates. We hypothesized that increasing unacceptable antigens to transition candidates from 80-98%…2016 American Transplant Congress
The Correlation of Hepatic and Systemic Hemodynamics During Liver Transplantation: Quantification of Hepatic Resistance as an Actual Value.
Surgery, Tri-Service General Hospital, National Defense Medical Center, Taipei, Taiwan.
PurposeThe correlation between portal vein pressure (PVP) and flow (PVF) has not been established, and there is still lack of consensus about the optimal hemodynamics…2016 American Transplant Congress
Outcomes Following Inguinal Hernia Repair in Liver Transplant Recipients.
Surgery, Johns Hopkins, Baltimore.
Liver transplant (LT) recipients are assumed to have poor outcomes following general surgical procedures, which may be a reason why most are directed to transplant…2016 American Transplant Congress
Outcomes Following Appendectomy in Kidney Transplant Recipients.
Surgery, Johns Hopkins, Baltimore.
Case series suggest kidney transplant (KT) recipients have higher complication rates and longer length of stay (LOS) following appendectomy than non-transplant patients. This study investigates…2016 American Transplant Congress
Early Hospital Readmission After Kidney Transplantation: Seasonality, Causes and Prognosis.
Background: In the general population, 30-day hospital readmission rate is a well-accepted quality metric and a predictor of mortality. A growing body of data suggests…2016 American Transplant Congress
An Evaluation of the Safety, Efficacy, and Pharmacoeconomics of Two Valganciclovir Prophylaxis Regimens Following Renal Transplantation.
1IU Health, University Hospital, Indianapolis, IN; 2Butler University, Indianapolis, IN.
Valganciclovir is the preferred prophylactic therapy for the prevention of CMV in transplant recipients and is the most expensive medication required post transplantation. The objective…2016 American Transplant Congress
Outcomes of Solid Organ Transplantation from an HIV Positive Donor to Negative Recipients.
Purpose:There are few case reports about outcomes of solid organ transplantation from human immunodeficiency virus (HIV)-positive donor to HIV-negative recipient. We would like to share…2016 American Transplant Congress
The Combined Effect of Acute Rejection and De Novo Donor-Specific Antibodies on Kidney Allograft Survival.
Division of Renal Diseases and Hypertension, University of Colorado, Aurora, CO.
While dnDSA is associated with graft loss in multiple studies, the clinical context in which dnDSA develops and contributes to graft loss is less well…2016 American Transplant Congress
The Impact of Microvascular Inflammation (MVI) in Kidney Transplant Biopsies (KTxBx) Is Independent of Time Post-Transplant.
Detection of MVI in a KTxBx, often associated with antibody mediated rejection, is associated with a poor prognosis for kidney graft survival. However most information…2016 American Transplant Congress
Improved Regeneration of the Remnant Liver After Extended Hepatectomy or Partial Liver Transplantation by Pharmacologic Mobilization of Endogenous Stem Cells in Rats.
Department of Surgery, Johns Hopkins University School of Medicine, Baltimore, MD.
BackgroundRapid regeneration of the remnant liver after extended partial hepatectomy or reduced size liver transplantation is essential to prevent small-for-size syndrome (SFSS). We hypothesize that…
- « Previous Page
- 1
- …
- 151
- 152
- 153
- 154
- 155
- …
- 180
- Next Page »